5029 POSTER Early termination of a phase II study of the Austrian AGO: Weekly docetaxel and irinotecan in platinum-refractory and resistant ovarian cancer
Petru, E., Angleitner-Boubenizek, L., Reinthaller, A., Volgger, B., Kohlberger, P., Deibl, M., Bogner, G., Wolfram, G., Marth, C.Том:
5
Мова:
english
Журнал:
European Journal of Cancer Supplements
DOI:
10.1016/S1359-6349(07)71201-6
Date:
September, 2007
Файл:
PDF, 61 KB
english, 2007